GenePharm

Genepharm S.A., founded in 1998, is a private, commercial-stage pharmaceutical manufacturer headquartered in Zurich, Switzerland, with its primary production operations in Greece. The company leverages its 12,000 m² EU GMP-certified factory to produce a wide range of generic and branded pharmaceuticals across multiple therapeutic areas, with a specific focus on oncology solids. Its business model is centered on manufacturing, product development, and global distribution via partnerships, generating revenue through sales and contract services. While systematically strengthening its position in the Greek market, Genepharm has established an extensive international footprint through collaborations with global pharmaceutical companies.

EU GMP-certified, dual-line manufacturing platform for solid oral dosage forms, with specialized, segregated production capacity for conventional and oncology products.

Genepharm competes in the global generic and specialty pharmaceutical manufacturing sector against large multinational generics companies (e.g., Teva, Sandoz) and other regional EU manufacturers. Its competitive differentiation lies in its modern, dedicated oncology production line and its strategic location combining EU standards with a cost-effective operational base.